Peter Dall

4.7k citations

97 papers · 2.5k indexed · h-index 30

Impact in

Oncology top 5%
- CAR-T cell therapy research
Genetics top 2%
- Virus-based gene therapy research

Papers in ⓘ

Oncology 35
- CAR-T cell therapy research 12
- HER2/EGFR in Cancer Research 7
Obstetrics and Gynecology 8

Co-authors: Claus Lindegaard (10 shared papers)Helmut Ponta (8 shared papers)Peter Herrlich (9 shared papers)Kirsten Hamburger (7 shared papers)David T. Curiel (14 shared papers)Armin Hekele (6 shared papers)S. Djahansouzi (7 shared papers)Karl‐Heinz Heider (2 shared papers)
Journals: International Journal of Cancer (9 papers)Hydrobiologia (7 papers)Cancer Gene Therapy (3 papers)Breast Cancer Research (3 papers)Journal of Clinical Oncology (3 papers)
Partner nations: Germany United States Denmark

In The Last Decade

Peter Dall

89 papers receiving 2.4k citations

Peers

Countries citing papers authored by Peter Dall

Since Specialization

Citations

This map shows the geographic impact of Peter Dall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Dall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Dall more than expected).

Fields of papers citing papers by Peter Dall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Dall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Dall. The network helps show where Peter Dall may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Dall, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Dall Line = papers co-authored together Peter Dall links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 97 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma Breast Cancer Research and Treatment ·Mariam A. Stoff‐Khalili, Ángel A. Rivera, J. Michael Mathis, N. Sanjib Banerjee, Amanda S. Moon, Angela R. Hess, Rodney P. Rocconi, T. Michael Numnum, Maaike Everts, Louise T. Chow, Joanne T. Douglas, Gene P. Siegal, Zeng B. Zhu, Hans Bender, Peter Dall, Alexander Stoff, L Pereboeva, David T. Curiel	2007	157
2	Comparison of immunohistochemistry and RT‐PCR for detection of CD44v‐expression, a new prognostic factor in human breast cancer International Journal of Cancer ·Peter Dall, Karl‐Heinz Heider, Hans‐Peter Sinn, Petra Skroch‐Angel, Günther R. Adolf, Manfred Kaufmann, Peter Herrlich, Helmut Ponta	1995	136
3	Treatment of ovarian cancer with a tropism modified oncolytic adenovirus. PubMed ·Gerd Bauerschmitz, John Lam, Anna Kanerva, Kaori Suzuki, Dirk M. Nettelbeck, Igor P. Dmitriev, Victor Krasnykh, Galina Mikheeva, Mack N. Barnes, Ronald D. Alvarez, Peter Dall, Ramón Alemany, David T. Curiel, Akseli Hemminki	2002	130
4	Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium. PubMed ·Peter Dall, Karl‐Heinz Heider, Armin Hekele, G von Minckwitz, Martin Kaufmann, Helmut Ponta, Peter Herrlich	1994	114
5	The fauna in the upper stony littoral of Danish lakes: macroinvertebrates as trophic indicators Freshwater Biology ·Klaus P. Brodersen, Peter Dall, Claus Lindegaard	1998	81
6	Insights into the molecular biology of the estrogen receptor define novel therapeutic targets for breast cancer European Journal of Endocrinology ·Bettina Hanstein, S. Djahansouzi, Peter Dall, MW Beckmann, HG Bender	2004	75
7	Radical resection of invasive endometriosis with bowel or bladder involvement—Long-term results European Journal of Obstetrics & Gynecology and Reproductive Biology ·Markus C. Fleisch, Dimitris Xafis, F. De Bruyne, J. Hucke, Hans Bender, Peter Dall	2005	72
8	Limited relevance of the CHEK2 gene in hereditary breast cancer International Journal of Cancer ·Michael R. Dufault, Beate Betz, Barbara Wappenschmidt, Wera Hofmann, Katrin Bandick, Astrid Golla, Andrea Pietschmann, C. Nestle-Krämling, Kerstin Rhiem, Christine Hüttner, Celia von Lindern, Peter Dall, Marion Kiechle, Michael Untch, W. Jonat, Alfons Meindl, Siegfried Scherneck, Dieter Niederacher, Rita K. Schmutzler, Norbert Arnold	2004	70
9	Regression of Cutaneous Tumor Lesions in Patients Intratumorally Injected with a Recombinant Single-chain Antibody-toxin Targeted to ErbB2/HER2 Breast Cancer Research and Treatment ·Marc Azémar, S. Djahansouzi, Elke Jäger, Christine Solbach, Mathias Schmidt, Alexander Maurer, K. Mross, Clemens Unger, Gϋnter von Minckwitz, Peter Dall, Bernd Groner, Winfried S. Wels	2003	69
10	A Sampling Technique for Littoral Stone Dwelling Organisms Oikos ·Peter Dall	1979	68
11	Expression of the hyaluronan receptor RHAMM in endometrial carcinomas suggests a role in tumour progression and metastasis Journal of Cancer Research and Clinical Oncology ·DT Rein, Karla L. Roehrig, Thomas Schöndorf, Agata Lazar, Markus C. Fleisch, Dieter Niederacher, H Bender, Peter Dall	2003	61
12	Predictors for long‐term survival after interdisciplinary salvage surgery for advanced or recurrent gynecologic cancers Journal of Surgical Oncology ·Markus C. Fleisch, P Pantke, M.W. Beckmann, H.G. Schnuerch, R. Ackermann, Marc‐Oliver Grimm, H. G. Bender, Peter Dall	2006	55
13	Triple-Targeted Oncolytic Adenoviruses Featuring the Cox2 Promoter, E1A Transcomplementation, and Serotype Chimerism for Enhanced Selectivity for Ovarian Cancer Cells Molecular Therapy ·Gerd Bauerschmitz, Kilian Guse, Anna Kanerva, Artur Menzel, Isabell Herrmann, Renée A. Desmond, Masato Yamamoto, Dirk M. Nettelbeck, Tanja Hakkarainen, Peter Dall, David T. Curiel, Akseli Hemminki	2006	55
14	The CD44 Proteins in Embryonic Development and in Cancer Current topics in microbiology and immunology ·Larry S. Sherman, Jonathan P. Sleeman, Peter Dall, Armin Hekele, Jürgen Moll, Helmut Ponta, Peter Herrlich	1996	52
15	Distinct Expression Patterns of CD44 Isoforms During Human Lung Development and in Pulmonary Fibrosis American Journal of Respiratory Cell and Molecular Biology ·M. Kasper, Ursula Günthert, Peter Dall, K Kayser, D. Schuh, G. Haroske, Martín Müller	1995	50
16	Activity of the DNA repair protein O6-methylguanine-DNA methyltransferase in human tumor and corresponding normal tissue. PubMed ·Ilka Preuss, Simone Haas, Uta Eichhorn, I Eberhagen, Muriel Kaufmann, Tim N. Beck, Robert H. Eibl, Peter Dall, Thomas Bauknecht, Jan G. Hengstler, Wittig Bm, Wolfgang Dippold, Bernd Kaina	1996	50
17	Hormone Replacement Therapy after Treatment of Breast Cancer: Effects on Postmenopausal Symptoms, Bone Mineral Density and Recurrence Rates Oncology ·Matthias W. Beckmann, D. Jap, S. Djahansouzi, Carolin Nestle-Krämling, Bettina Kuschel, Peter Dall, C. Brumm, Hans Bender	2001	48
18	Prognostic value of CD44 variant expression in primary breast cancer International Journal of Cancer ·John A. Foekens, Peter Dall, Jan G.M. Klijn, Petra Skroch-Angel, Cassandra J.C. Claassen, Maxime P. Look, Helmut Ponta, Wim L.J. van Putten, Peter Herrlich, Sonja C. Henzen‐Logmans	1999	48
19	Efficacy and Safety of AEZS-108 (LHRH Agonist Linked to Doxorubicin) in Women With Advanced or Recurrent Endometrial Cancer Expressing LHRH Receptors International Journal of Gynecological Cancer ·G. Emons, G Gorchev, Philipp Harter, Pauline Wimberger, Anne Stähle, Lars Hanker, Felix Hilpert, Matthias W. Beckmann, Peter Dall, Carsten Gruindker, H. Sindermann, Jalid Sehouli	2014	47
20	Growth retardation of tumors by adoptive transfer of cytotoxic T lymphocytes reprogrammed by CD44V6-specific SCFV: ζ-chimera International Journal of Cancer ·Armin Hekele, Peter Dall, Dirk Moritz, Winfried S. Wels, Bernd Groner, Peter Herrlich, Helmut Ponta	1996	46

About Peter Dall

Peter Dall is a scholar working on Oncology, Obstetrics and Gynecology, Nature and Landscape Conservation, Ecology and Genetics, having authored 97 papers that have together received 2.5k indexed citations. Recurring topics across this work include Aquatic Invertebrate Ecology and Behavior (19 papers), Virus-based gene therapy research (17 papers), CAR-T cell therapy research (12 papers), Proteoglycans and glycosaminoglycans research (12 papers), Freshwater macroinvertebrate diversity and ecology (12 papers), Fish Ecology and Management Studies (11 papers), Glycosylation and Glycoproteins Research (8 papers) and HER2/EGFR in Cancer Research (7 papers). The work is most often cited by research in Oncology (805 citations), Genetics (752 citations), Immunology and Allergy (154 citations), Cell Biology (386 citations) and Obstetrics and Gynecology (163 citations). Peter Dall has collaborated with scholars based in Germany, United States and Denmark. Frequent co-authors include Claus Lindegaard, Helmut Ponta, Peter Herrlich, Kirsten Hamburger, David T. Curiel, Armin Hekele, S. Djahansouzi, Karl‐Heinz Heider, Mariam A. Stoff‐Khalili and Hans Bender. Their work appears in journals such as International Journal of Cancer, Hydrobiologia, Cancer Gene Therapy, Breast Cancer Research and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact